Thyroid-associated orbitopathy

Ophthalmology. 2010 Sep;117(9):1864; author reply 1864-5. doi: 10.1016/j.ophtha.2010.05.006.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • B-Lymphocytes / drug effects
  • Drug Resistance*
  • Exophthalmos / diagnosis
  • Exophthalmos / physiopathology
  • Flow Cytometry
  • Glucocorticoids / therapeutic use*
  • Graves Ophthalmopathy / drug therapy*
  • Graves Ophthalmopathy / immunology
  • Graves Ophthalmopathy / physiopathology
  • Humans
  • Immunoenzyme Techniques
  • Immunologic Factors / administration & dosage*
  • Immunologic Factors / adverse effects
  • Infusions, Intravenous
  • Lymphocyte Count
  • Lymphocyte Depletion
  • Orbit / metabolism
  • Orbit / pathology
  • Rituximab
  • Strabismus / diagnosis
  • Strabismus / physiopathology
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Glucocorticoids
  • Immunologic Factors
  • Rituximab